Territory Planning: Develop and execute comprehensive territory plans targeting immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centers
Account Prioritization: Identify and prioritize high-value accounts based on HAE patient volume, prescriber influence, and institutional capabilities
Relationship Building: Establish trusted advisor relationships with key opinion leaders, clinical champions, and administrative decision-makers
Pipeline Management: Maintain robust sales pipeline tracking opportunities from initial awareness through patient treatment completion
Scientific Education & Communication
CRISPR Technology Education: Educate healthcare providers on in vivo CRISPR gene editing mechanisms, differentiating from ex vivo cell therapies and traditional treatments
MOA Differentiation: Clearly articulate the unique mechanism of action compared to prophylactic treatments, complement inhibitors, and plasma-derived therapies
Clinical Data Presentation: Present Phase III efficacy and safety data
Technology Positioning: Address misconceptions about CRISPR safety and differentiate from previous gene therapy launches
Disease Education: educate healthcare providers about unmet needs affecting disease management and treatment burden
Competitive Differentiation
Competitive Intelligence: Maintain deep understanding of competitive landscape and emerging therapies
Value Proposition Development: Articulate differentiated value propositions versus existing HAE treatments and other gene therapies
Objection Handling: Proactively address concerns about CRISPR technology, permanent genetic modification, and single-treatment cost
**Company Differentiation**: Position organization as innovative leader with superior clinical acumen
Complex Treatment Pathway Managemen t
Patient Journey Education : Educate on the patient pathway from diagnosis confirmation through treatment administr ation
Hub Services Integratio n : Coordinate with patient support hubs to ensure seamless patient experience and treatment access
Cross-Functional Collaboratio n
Medical Affairs Partnership: Coordinate with Medical Science Liaisons to seamlessly address customers' medical and clinical informational needs
Market Access Alignment: Work closely with Field Reimbursement Managers on payer strategy and coverage optimization
Strategic Accounts : Partner with strategic accounts team to understand referral patterns, site selection, and site activation for procurement and administration of the therapy
About You:
Scientific & Technical Knowledge
HAE Understanding: Comprehensive knowledge of hereditary angioedema pathophysiology, treatment landscape, and unmet medical needs
CRISPR/Gene Therapy Familiarity: Understanding of gene editing technologies, genetic medicines, and regulatory requirements
**Clinical Data Interpretation**: Ability to analyze and present complex clinical trial data and real-world evidence
Skills & Competencies
Scientific Communication: Exceptional ability to communicate complex scientific concepts to diverse healthcare audiences
Customer Alignment & Relationship Management: Proven ability to build and maintain long-term relationships with key stakeholders
Problem Solving: Creative approach to overcoming access barriers and treatment implementation ch
Benefits
Health insurance
Additional Information
Why Join Intellia?
Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.
We want all of our people to go beyond what is possible. We aren't constrained by typical end rails, and we aren't out to just "treat" people. We're all in this for something more. We're driven to cure and motivated for change. Just imagine the possibilities of what we can do together.
How You Will Achieve More:
We are seeking an exceptional Sales Representative to lead the commercial launch of our groundbreaking in vivo CRISPR therapy for hereditary angioedema (HAE). This role represents a career defining opportunity to pioneer the commercialization of the first-ever, single treatment gene editing therapy . The successful candidate will be responsible for introducing healthcare providers to the first-ever in vivo CRISPR therapy, requiring sophisticated scientific communication, complex stakeholder management, and exceptional execution within a highly competitive rare disease market.
This territory will cover Louisiana, Mississippi and Alabama.
Intelliatx · Cambridge, MA